✦ LIBER ✦

Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization-Positive/Phospho-Akt-Positive or Never Smoker Patients With Advanced Non-Small-Cell Lung Cancer: The ONCOBELL Trial

✍ Scribed by Cappuzzo, F.; Ligorio, C.; Janne, P. A.; Toschi, L.; Rossi, E.; Trisolini, R.; Paioli, D.; Holmes, A. J.; Magrini, E.; Finocchiaro, G.; Bartolini, S.; Cancellieri, A.; Ciardiello, F.; Patelli, M.; Crino, L.; Varella-Garcia, M.

Book ID: 118025572
Publisher: American Society of Clinical Oncology
Year: 2007
Tongue: English
Weight: 130 KB
Volume: 25
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2006.09.4300

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

53 A phase I study of epidermal growth f

53 A phase I study of epidermal growth factor receptor (EGFR) antibody EMD 72000 in combination with paclitaxel (P) in patients (pts) with EGFR-positive advanced non-small cell lung cancer (NSCLC)

✍ C. Bokemeyer; C. Kollmannsberger; M. Schittenhelm; F. Honecker; H.J. Ahrens; J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 334 KB

O-245 Randomized phase II clinical trial

O-245 Randomized phase II clinical trial of cetuximab in combination with cisplatin and vinorelbine or cisplatin and vinorelbine alone in patients (pts) with advanced epidermal growth factor receptor (EGFR)-positive non-small-cell lung cancer (NSCLC)

✍ Rosell, Rafael; Constenla, Manuel; Kolb, Rainer; Pfeiffer, Wolfang; O'Bryne, Ken 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB